Meacor
Meacor Inc. is dedicated to developing innovative solutions for heart valve regurgitation, focusing on minimally invasive procedures to improve patient outcomes. Their mission is to address the large unmet clinical need for safer, less invasive treatments for valve diseases, leveraging advanced technology such as cryoadhesion and novel anchoring techniques.
Industries
Nr. of Employees
small (1-50)
Products
Investigational catheter-based cryo-anchoring annuloplasty system
An investigational, catheter-delivered system that uses cryoadhesion to anchor devices around the valve annulus and a cinching mechanism to reduce annular diameter in a beating heart procedure; intended as a transcatheter alternative to open surgical annuloplasty.
Investigational catheter-based cryo-anchoring annuloplasty system
An investigational, catheter-delivered system that uses cryoadhesion to anchor devices around the valve annulus and a cinching mechanism to reduce annular diameter in a beating heart procedure; intended as a transcatheter alternative to open surgical annuloplasty.
Services
Partnerships and research collaborations
Engagements with research institutions, accelerator programs, and industry partners to advance preclinical development and commercialization of the device.
Partnerships and research collaborations
Engagements with research institutions, accelerator programs, and industry partners to advance preclinical development and commercialization of the device.
Expertise Areas
- Transcatheter valve repair
- Minimally invasive cardiac device development
- Catheter and steerable sheath design
- Cryoadhesion technology for tissue anchoring
Key Technologies
- Cryoadhesion-based tissue anchoring
- Transcatheter annuloplasty
- Steerable catheter systems
- Low-profile catheter/sheath design (15 Fr class)